The following table provides a reconciliation of the number of shares outstanding for basic and diluted earnings per share:

	For the three months ended
	May 1, 2021		May 2, 2020
(in thousands)
Common stock outstanding:
Basic weighted average common shares outstanding		62,153		50,758
Common stock equivalents – stock options, restricted stock units and deferred stock ⁽¹⁾		847		—
Diluted weighted average common shares outstanding		63,000		50,758

The following potential common stock equivalents were excluded from the computation of diluted earnings per share in each period, because the exercise price of such options was greater than the average market price per share of common stock for the respective periods or because the unearned compensation associated with stock options, restricted stock units, or deferred stock had an anti-dilutive effect.

	For the three months ended
	May 1, 2021		May 2, 2020
(in thousands, except exercise prices)
Stock options		1,933		538
Restricted stock units		506		963
Deferred stock		102		160
Range of exercise prices of such options	$0.69 - $5.50		$1.85 - $7.02

The above options, which were outstanding at May 1, 2021, expire from January 31, 2023 to March 9, 2031.

Excluded from the computation of basic and diluted earnings per share for both periods were 720,000 shares of unvested performance stock units. These performance-based awards will be included in the computation of basic and diluted earnings per share if, and when, the respective performance targets are achieved. In addition, 435,568 shares and 335,073 shares of deferred stock at May 1, 2021 and May 2, 2020, respectively, were excluded from basic earnings per share. Outstanding shares of deferred stock are not considered issued and outstanding until the vesting date of the deferral period.